Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612 1622 1629
This examiner grants 34% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19446148 | METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS | Final Rejection | Sparrow Pharmaceuticals, Inc. |
| 17728246 | WHOLE MOUTH MALADOR CONTROL BY A COMBINATION OF ANTIBACTERIAL AND DEODORIZING AGENTS | Final Rejection | The Procter & Gamble Company |
| 17899272 | METHODS AND MATERIALS FOR ASSESSING AND TREATING ARTHRITIS | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 17437643 | COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH | Non-Final OA | The Regents of the University of California |
| 17760621 | IDENTIFICATION OF COMPOUNDS THAT INHIBIT STRESS GRANULE FORMATION AND TAU AGGREGATION BY TARGETING TIAI | Non-Final OA | The Trustees Of Columbia University In The City Of New York |
| 17256640 | COMPOSITIONS AND METHODS FOR MEDIATING EPS | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 18255518 | RESTORATION OF MOTOR FUNCTION POST-NEUROLOGICAL INJURY USING PSYCHEDELICS | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18638133 | BLOCKADE OF CHEMOKINE (C-C MOTIF) RECEPTOR 2 DURING FLUID RESUSCITATION | Final Rejection | University of South Florida |
| 17387129 | INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN | Final Rejection | Southwest Research Institute |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy